152 related articles for article (PubMed ID: 38297974)
1. Comparison of prediction models for cardiovascular and mortality risk in people with type 2 diabetes: An external validation in 23 685 adults included in the UK Biobank.
Zhang Y; Jiong OX; Tang S; Tang YC; Wong CT; Ng CS; Quan J
Diabetes Obes Metab; 2024 May; 26(5):1697-1705. PubMed ID: 38297974
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of the CHIME simulation model to assess lifetime health outcomes of prediabetes and type 2 diabetes in Chinese populations: A modeling study.
Quan J; Ng CS; Kwok HHY; Zhang A; Yuen YH; Choi CH; Siu SC; Tang SY; Wat NM; Woo J; Eggleston K; Leung GM
PLoS Med; 2021 Jun; 18(6):e1003692. PubMed ID: 34166382
[TBL] [Abstract][Full Text] [Related]
3. Risk Prediction Scores for Mortality, Cerebrovascular, and Heart Disease Among Chinese People With Type 2 Diabetes.
Quan J; Pang D; Li TK; Choi CH; Siu SC; Tang SY; Wat NM; Woo J; Lau ZY; Tan KB; Leung GM
J Clin Endocrinol Metab; 2019 Dec; 104(12):5823-5830. PubMed ID: 31287503
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.
Basu S; Sussman JB; Berkowitz SA; Hayward RA; Yudkin JS
Lancet Diabetes Endocrinol; 2017 Oct; 5(10):788-798. PubMed ID: 28803840
[TBL] [Abstract][Full Text] [Related]
5. Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S.
Basu S; Sussman JB; Berkowitz SA; Hayward RA; Bertoni AG; Correa A; Mwasongwe S; Yudkin JS
Diabetes Care; 2018 Mar; 41(3):586-595. PubMed ID: 29269511
[TBL] [Abstract][Full Text] [Related]
6. Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort.
Laxy M; Schöning VM; Kurz C; Holle R; Peters A; Meisinger C; Rathmann W; Mühlenbruch K; Kähm K
Pharmacoeconomics; 2019 Dec; 37(12):1485-1494. PubMed ID: 31350720
[TBL] [Abstract][Full Text] [Related]
7. Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort.
Keng MJ; Leal J; Mafham M; Bowman L; Armitage J; Mihaylova B
Value Health; 2022 Mar; 25(3):435-442. PubMed ID: 35227456
[TBL] [Abstract][Full Text] [Related]
8. In people with type 2 diabetes, sarcopenia is associated with the incidence of cardiovascular disease: A prospective cohort study from the UK Biobank.
Boonpor J; Pell JP; Ho FK; Celis-Morales C; Gray SR
Diabetes Obes Metab; 2024 Feb; 26(2):524-531. PubMed ID: 37881162
[TBL] [Abstract][Full Text] [Related]
9. Prediction of mortality and major cardiovascular complications in type 2 diabetes: External validation of UK Prospective Diabetes Study outcomes model version 2 in two European observational cohorts.
Pagano E; Konings SRA; Di Cuonzo D; Rosato R; Bruno G; van der Heijden AA; Beulens J; Slieker R; Leal J; Feenstra TL
Diabetes Obes Metab; 2021 May; 23(5):1084-1091. PubMed ID: 33377255
[TBL] [Abstract][Full Text] [Related]
10. Predictive performance of established cardiovascular risk scores in the prediabetic population: external validation using the UK Biobank data set.
Li M; Lin Y; Zhong X; Huang R; Zhang S; Liu M; Liu S; Ye X; Xu X; Huang Y; Xiong Z; Guo Y; Liao X; Zhuang X
Eur J Prev Cardiol; 2023 Oct; 30(14):1427-1438. PubMed ID: 37036042
[TBL] [Abstract][Full Text] [Related]
11. Diabetes with poor-control HbA1c is cardiovascular disease 'risk equivalent' for mortality: UK Biobank and Hong Kong population-based cohort study.
Wan EYF; Yu EYT; Mak IL; Youn HM; Chan KS; Chan EWY; Wong ICK; Lam CLK
BMJ Open Diabetes Res Care; 2023 Jan; 11(1):. PubMed ID: 36634978
[TBL] [Abstract][Full Text] [Related]
12. Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses.
Buchan TA; Malik A; Chan C; Chambers J; Suk Y; Zhu JW; Ge FZ; Huang LM; Vargas LA; Hao Q; Li S; Mustafa RA; Vandvik PO; Guyatt G; Foroutan F
Heart; 2021 Dec; 107(24):1962-1973. PubMed ID: 33833070
[TBL] [Abstract][Full Text] [Related]
13. Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the Basque Country Prospective Complications and Mortality Study risk engine (BASCORE).
Piniés JA; González-Carril F; Arteagoitia JM; Irigoien I; Altzibar JM; Rodriguez-Murua JL; Echevarriarteun L;
Diabetologia; 2014 Nov; 57(11):2324-33. PubMed ID: 25212259
[TBL] [Abstract][Full Text] [Related]
14. Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.
Schmucker C; Eisele-Metzger A; Meerpohl JJ; Lehane C; Kuellenberg de Gaudry D; Lohner S; Schwingshackl L
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013556. PubMed ID: 35199850
[TBL] [Abstract][Full Text] [Related]
15. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
16. Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank.
Parsons RE; Liu X; Collister JA; Clifton DA; Cairns BJ; Clifton L
Heart; 2023 Oct; 109(22):1690-1697. PubMed ID: 37423742
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease.
Ganz P; Heidecker B; Hveem K; Jonasson C; Kato S; Segal MR; Sterling DG; Williams SA
JAMA; 2016 Jun; 315(23):2532-41. PubMed ID: 27327800
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
Davis WA; Colagiuri S; Davis TM
Med J Aust; 2009 Feb; 190(4):180-4. PubMed ID: 19220181
[TBL] [Abstract][Full Text] [Related]
19. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
[TBL] [Abstract][Full Text] [Related]
20. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
